Change in brain cells linked to opiate addiction, narcolepsy
This study was supported by grants from the National Institute on Drug Abuse and the Medical Research Service of the U.S. Department of Veterans Affairs. (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - June 27, 2018 Category: Universities & Medical Training Source Type: news
A wakefulness molecule is abundant in the brains of heroin addicts
(American Association for the Advancement of Science) Researchers have discovered that the brains of heroin addicts harbor a greater number of neurons that produce hypocretin, a molecule involved in arousal and wakefulness, and one lacking in abundance in people with narcolepsy. In mice with narcolepsy, these researchers went on to show, administering morphine -- an opioid similar. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 27, 2018 Category: International Medicine & Public Health Source Type: news
Change in brain cells linked to opiate addiction, narcolepsy
(University of California - Los Angeles) Two discoveries -- one in the brains of people with heroin addiction and the other in the brains of sleepy mice -- shed light on chemical messengers in the brain that regulate sleep and addiction. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 27, 2018 Category: International Medicine & Public Health Source Type: news
What is the Prevalence of Somnambulism?
Discussion
Sleep disorders are common in all ages particularly sleep deprivation in our increasingly busy world. A review of health problems caused by inadequate sleep can be found here. Sleep problems are more common in patients with attention deficit hyperactivity disorder, epilepsy, headache and visual impairments. Sleep problems can cause cognitive and behavioral impairments including emotional regulation problems, increased seizures or headaches, and impaired attention and has been known to prolong recovery from various acquired brain injuries.
Somnambulism or sleepwalking is a parasomnia (which include confusional a...
Source: PediatricEducation.org - June 25, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Medical News Today: What is Evekeo?
Evekeo is an amphetamine-based medication that is used to treat narcolepsy, ADHD, and excess weight. Evekeo is the trade name as there is no generic amphetamine drug. It is a controlled substance, due to the risk of dependence and adverse effects. Find out more about this drug, its uses, and the risks involved. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 20, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news
New Drug for Narcolepsy, Sleep Apnea on the Horizon New Drug for Narcolepsy, Sleep Apnea on the Horizon
Solriamfetol showed durable effects in reducing excessive sleepiness in patients with narcolepsy or obstructive sleep apnea in a long-term study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 12, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Harmony's lead new drug candidate receives 2 FDA designations
The experimental therapy is being developed to treat cataplexy and narcolepsy. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 31, 2018 Category: American Health Authors: John George Source Type: news
From narcolepsy to apnoea: the science of sleep disorders
Biologist and narcoleptic Henry Nicholls explores what happens when sleep goes wrong (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 24, 2018 Category: Pharmaceuticals Source Type: news
Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2
(MedPage Today) -- Higher dosages showed greater improvements (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 25, 2018 Category: Psychiatry Source Type: news
Novel Agent Significantly Curbs Excessive Sleepiness in Narcolepsy Novel Agent Significantly Curbs Excessive Sleepiness in Narcolepsy
A novel agent currently in development helps those with type 1 or type 2 narcolepsy experience less excessive sleepiness, enabling them to maintain wakefulness for longer periods.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Medical News Today: Coping with an Adderall crash
Adderall is a stimulant medication that is used to treat ADHD or narcolepsy. When a person stops taking Adderall too quickly, they can experience withdrawal symptoms, such as sleep problems or depression. Here, we look at the causes and timeline of an Adderall crash and give tips and remedies for coping if it happens. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2018 Category: Consumer Health News Tags: ADHD / ADD Source Type: news
Study points to potential misuse/abuse of ADHD drugs
(Wiley) A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2018 Category: International Medicine & Public Health Source Type: news
Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 2, 2018 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company's New Drug Application (ND... Biopharmaceuticals, FDA Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news
Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 2, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company ' s New Drug Application (NDA) seeking marketing... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 2, 2018 Category: Drugs & Pharmacology Source Type: news
Narcolepsy causes woman to pass out every time she laughs
Sam Hart, 20, from Luton, suffers from narcolepsy, which has left her 'robbed of her independence' and with 'hardly any quality of life'. She is unable to take medication after it made her want to start fires. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2018 Category: Consumer Health News Source Type: news
